Siemens Healthineers : Strong comparable sales growth, weak margins in Q4
>Strong comparable sales, but weak margin in Q4 - Comparable sales growth was 14.4% y-o-y in Q4 (vs our estimate of 11.6% y-o-y and consensus of 10.6% y-o-y), a strong performance driven by all established divisions. We are positively surprised by Imaging (+11.6% y-o-y) and note that Diagnostics was better again in Q4. This was helped by antigen test sales against the new coronavirus (€ 160m vs € 80m estimated). Varian performance was weaker than expected (only second...Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company is developing its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value. Siemens AG is a majority shareholder of the Company. The Company is active worldwide.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.